This Krystal Biotech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday – Abeona Therapeutics (NASDAQ:ABEO), Fluence Energy (NASDAQ:FLNC)

Mar 5, 2025
this-krystal-biotech-analyst-begins-coverage-on-a-bullish-note;-here-are-top-5-initiations-for-wednesday-–-abeona-therapeutics-(nasdaq:abeo),-fluence-energy-(nasdaq:flnc)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Canaccord Genuity analyst John Newman initiated coverage on Marker Therapeutics, Inc. MRKR with a Buy rating and announced a price target of $8. Marker Therapeutics shares closed at $1.38 on Tuesday. See how other analysts view this stock.
  • Jefferies analyst Roger Song initiated coverage on Krystal Biotech, Inc. KRYS with a Buy rating and announced a price target of $245. Krystal Biotech shares closed at $175.22 on Tuesday. See how other analysts view this stock.
  • Barclays analyst Thomas O’Malley initiated coverage on Sandisk Corporation SNDK with an Equal-Weight rating and announced a price target of $50. SanDisk shares closed at $48.69 on Tuesday. See how other analysts view this stock.
  • Mizuho analyst Maheep Mandloi initiated coverage on Fluence Energy, Inc. FLNC with an Outperform rating and announced a price target of $8. Fluence Energy shares closed at $5.21 on Tuesday. See how other analysts view this stock.
  • Oppenheimer analyst Francois Brisebois initiated coverage on Abeona Therapeutics Inc. ABEO with an Outperform rating and announced a price target of $16. Abeona Therapeutics shares closed at $5.07 on Tuesday. See how other analysts view this stock.

Read This Next:

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

date

ticker

name

Price Target

Upside/Downside

Recommendation

Firm

Analyst Calendar

Join Benzinga Edge and unlock all the major upgrades, downgrades, and changes to the market’s most accurate analysts.


Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Already a member?Sign in

Benzinga.com on devices

Leave a comment